论文信息 - Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial - 字舞流文

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

Y. Arabi | A. Bouchama | Faisal Alharbi | M. Alzahrani | E. Mahmoud | S. Al Johani | Nasser M. Alqahtani | Khalid Ghalilah | M. Bosaeed | Hajar Alqahtani | M. Alshamrani | A. Alsaedy | O. Aldibasi | Abdullah O. Bawazir | J. AlJishi | M. Aljeraisy | A. Althaqafi | A. Alotaibi | Badriah M. Almutairi | Ahmad Alaskar | Malak S. Alharbi | Ahmad Alharbi | Hassan Almarhabi | S. Aleisa | Hawra Albayat | Hadeel Altayib | Abdulmajid Al Arfaj | A. Alarfaj | Manar Almaghaslah | Nawaf M. Alyahya | A. Alaskar | Faisal A Alharbi